Header Logo

Connection

MARIE-CLAUDE HOFMANN to Proto-Oncogene Proteins p21(ras)

Back to Details
This is a "connection" page, showing publications MARIE-CLAUDE HOFMANN has written about Proto-Oncogene Proteins p21(ras).
MARIE-CLAUDE HOFMANN
Connection Strength
0.348
Proto-Oncogene Proteins p21(ras)
  1. Long-term vemurafenib treatment drives inhibitor resistance through a spontaneous KRAS G12D mutation in a BRAF V600E papillary thyroid carcinoma model. Oncotarget. 2016 May 24; 7(21):30907-23.
    View in: PubMed
    Score: 0.348
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.